Prostate Cancer Treatment Expert, David B. Samadi, M.D, Announces Breakthrough with over 1,100 Robotic Prostatectomy Surgeries

New York, NY (PRWEB) November 12, 2007 -- Internationally respected for his surgical practice, Dr. Samadi discusses what it takes to be a leading robotic surgeon. He attributes his success to a top notch surgical team. He has operated with the same surgical team for many years; they rely on each other and drive the surgery to a successful completion. The expert group at Mount Sinai in New York City operates under Dr. Samadi's direction to seamlessly produce a 95% cure rate for his patients. The short average surgery time of 77 minutes means minimal risk to the patient under general anesthesia. There is less trauma to the patient because instead of making one five inch incision through the abdominal muscle to get at the prostate, the da Vinci surgical system makes five ¼ inch openings, sparing delicate tissues responsible for sexual functional and bladder control. Patients hardly notice these small surgical sites that heal quickly and leave little scarring. Traditional surgical methods involve lengthy sedation, which can cause adverse effects after surgery. Dr. Samadi exclaims that "approximately 97% of his patients are released from the hospital within 1 day after a robotic prostatectomy. Most recover full sexual function and urinary continence in a relatively short period of time."

Da Vinci robotic surgery merges laparoscopic and open surgical methods for treating prostate cancer. It is to Dr. Samadi's credit that he received special training in France with robotic surgery (http://www.roboticoncology.com/Robotic-Surgery.php) founder Dr. Claude Abbou and open surgical training with Dr. Peter Scardino. As a result of this specialized training and being a pioneer in the filed, he is able to extend his skills in new ways. He remarks, "It's like having three surgeons in one head." In addition to the benefits of speed and efficiency using the robotic surgical system, the delicate instruments are more sensitive than human hands and pick up fine characteristics of the prostate gland that would not be detected, even with the most gifted surgical touch. The magnified 3-D view allows for better visualization of the prostate cancer treatment (http://www.roboticoncology.com/Da-Vinci-Robotic-Prostatectomy.php) site. If the small-scaled structures can be seen more clearly, then the instruments can be precisely targeted to remove the cancerous cells. Most important, concludes Dr. Samadi, is the excellent oncologic outcome, which is paramount to the patient. He goes on to say, "There is no compromise using robotic surgery. My patients remain cancer-free and enjoy good health for many years."

Medical research shows that for treating prostate cancer (http://www.roboticoncology.com/Prostate-Cancer.php), the surgeon with the most experience and advanced training makes all the difference to a successful outcome for the patient. Dr. Samadi and his surgical group handle more than a dozen new cases each week. This high number is indicative of the promising outcome for his patients. Because of his widespread success, referrals come from a well-established network of contacts worldwide. Patients with prostate cancer (http://www.roboticoncology.com/Prostate-Cancer.php) should go directly to Dr. Samadi and his first class surgical team at Mount Sinai for the best possible results.

About David B. Samadi, MD and RoboticOncology.com

David B. Samadi, MD is Chief of Robotic Surgery and Minimal Invasive Surgery at Mount Sinai School of Medicine in Manhattan, New York. He is a board certified urologic oncologist, specializing in the diagnosis and treatment of bladder, kidney, and prostate cancer using minimally invasive procedures like da vinci robotic assisted surgery. If you would like more information about Dr. Samadi's state-of-the-art treatment options, including the robotic prostatectomy, please don't hesitate to call his office at 212-241-8779, or visit him on the web at http://www.roboticoncology.com

###